Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)
| Image |  |
|---|---|
| Description | scientific article published on 17 November 2020 |
| Author/s |
author: Jason J Zoeller Jennifer L Caswell Gregory R Bean Katherine Pogrebniak Michael F Press Dennis Slamon Sara A Hurvitz Christina Curtis Joan Brugge |
| Publication date | November 17, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |